NCT07483905

Brief Summary

This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Mar 2026Jul 2026

First Submitted

Initial submission to the registry

March 12, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

March 12, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 12, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Long-duration ChemotherapyNighttime Day HospitalCancer Care OrganizationPatient Preferences

Outcome Measures

Primary Outcomes (1)

  • Level of patient interest in a nighttime Day Hospital service for long-duration chemotherapy infusions

    Assessment of the level of interest among patients with gynecologic cancers in receiving long-duration chemotherapy infusions during nighttime hours in a Day Hospital setting, as evaluated through responses to an anonymous online survey.

    Baseline

Study Arms (1)

Patients with gynecologic cancers

Patients affected by gynecologic cancers receiving care at the participating institution who are invited to complete an anonymous online survey assessing their interest in a nighttime Day Hospital service for long-duration chemotherapy infusions.

Behavioral: online survey

Interventions

online surveyBEHAVIORAL

Participants will complete an anonymous online survey designed to assess their interest in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions.

Patients with gynecologic cancers

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with gynecologic cancers receiving care at the participating institution who are invited to complete an anonymous online survey assessing their interest in a nighttime Day Hospital service for long-duration chemotherapy infusions.

You may qualify if:

  • Female patients
  • aged 18 years or older
  • Diagnosis of a gynecologic cancer
  • Receiving care at the participating institution
  • Ability to independently understand and complete complete the anonymous online survey

You may not qualify if:

  • Inability to access or complete the online questionnaire or difficulty with reading and writing
  • Cognitive impairment
  • Patients currently hospitalized or in emergency settings.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, 00168, Italy

Location

MeSH Terms

Conditions

Patient Preference

Condition Hierarchy (Ancestors)

Patient SatisfactionTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Anna Fagotti

    Fondazione Policlinico Universitario A. Gemelli, IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 12, 2026

First Posted

March 19, 2026

Study Start

March 12, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations